Axon Enterprise Earnings Preview: What Wall Street Is Watching

Core Viewpoint - Axon Enterprise is experiencing significant stock pressure despite strong revenue growth, with a year-to-date decline of 24% and a notable earnings miss in Q3 2025, leading to heightened investor scrutiny ahead of Q4 results [1]. Group 1: Financial Performance - Axon's Q3 2025 revenue reached $711 million, reflecting a 31% year-over-year increase, marking the seventh consecutive quarter of over 30% growth [1]. - The reported EPS of $1.17 fell short of the consensus estimate of $1.54, resulting in a GAAP net loss of $2 million due to increased R&D and acquisition costs [1]. - For Q4 2025, management guidance estimates revenue between $750 million and $755 million, with a full-year revenue target of approximately $2.74 billion, indicating a 31% year-over-year growth [1]. Group 2: Margins and Growth Drivers - The adjusted gross margin in Q3 was 62.7%, down 50 basis points year-over-year, primarily impacted by tariffs on the Connected Devices segment [1]. - The Software segment grew 41% year-over-year to $305 million, with annual recurring revenue (ARR) reaching $1.3 billion, indicating strong growth potential [1]. - Year-to-date bookings increased over 30%, with expectations for a strong Q4 bookings quarter, particularly driven by the AI Era Plan, which is projected to represent over 10% of U.S. state and local bookings for the year [1]. Group 3: Market Sentiment and Analyst Outlook - Analyst consensus remains bullish, with 18 buy ratings and one hold, and a consensus price target of $783.68, suggesting significant upside potential from current trading levels [1]. - Recent insider sales, totaling 52, present a divergence worth monitoring as management prepares to address investor concerns [1]. - The market is looking for evidence that Axon's investment cycle is nearing its peak and that profitability will return without sacrificing growth investments [1].